|
Yale SPORE in Skin Cancer
|
5P50CA121974-05
|
$2,233,298
|
$2,233,298
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-31S1
|
$97,935
|
$979
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-32S1
|
$99,959
|
$1,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-32
|
$1,889,710
|
$18,897
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Xenograft-like rejection of tumors in a-gal glycolipids
|
5R01CA122019-03
|
$337,188
|
$168,594
|
GALILI, URI
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-26S1
|
$487,529
|
$4,875
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126 00580
|
$85,856
|
$4,293
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
VCU Minority-Based Community Clinical Oncology Program
|
2U10CA052784-20
|
$359,518
|
$3,595
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-20S1
|
$100,001
|
$1,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-20S2
|
$197,549
|
$1,975
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
5P50CA128323-03
|
$1,500,000
|
$45,000
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Validation of Grm1 as a Therapeutic Target in Melanoma
|
3R01CA124975-04S1
|
$59,364
|
$59,364
|
GOYDOS, JAMES
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Validation of Grm1 as a Therapeutic Target in Melanoma
|
5R01CA124975-04
|
$295,488
|
$295,488
|
GOYDOS, JAMES
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Vaccines to promote Tc-1-based targeting of tumor stroma
|
1R01CA140375-01A1
|
$305,608
|
$152,804
|
Storkus, Walter
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Vaccination with IL-15 DC to Generate Melanoma-specific Protective Memory T Cells
|
1R01CA140602-01A2
|
$409,401
|
$409,401
|
PALUCKA, ANNA KAROLINA
|
BAYLOR RESEARCH INSTITUTE
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S1
|
$101,020
|
$2,020
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S2
|
$148,912
|
$2,978
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-37
|
$4,795,480
|
$95,910
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UV/Vit D in radiologic technologists
|
ZIA CP010133 10416
|
$248,410
|
$49,682
|
Freedman, Michal
|
DCEG (NCI)
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-22
|
$2,399,682
|
$119,984
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Uses of GEM models for Translational Cancer Research
|
5U01CA141508-02
|
$800,533
|
$400,267
|
CHIN, LYNDA
|
DANA-FARBER CANCER INSTITUTE
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S1
|
$99,949
|
$999
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S2
|
$73,975
|
$740
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S3
|
$98,980
|
$990
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-35
|
$6,464,088
|
$64,641
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-26
|
$1,751,531
|
$17,515
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S6
|
$1,444,105
|
$28,882
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S7
|
$98,815
|
$1,976
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S1
|
$100,000
|
$1,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-23
|
$5,994,681
|
$59,947
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-03S1
|
$91,667
|
$4,583
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-03
|
$1,463,613
|
$73,181
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Tumor-Stroma Interacions in the Tumor Microenvironment
|
5U54CA126515-05
|
$1,134,010
|
$306,183
|
HYNES, RICHARD
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Tumor-Reactive Immune Cells Generated from Drosphila Antigen Presenting Cells
|
ZIA BC 011228
|
$197,709
|
$197,709
|
Yang, James
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$10,002
|
$500
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor gene expression in vitro and in vivo
|
ZIA BC 008905
|
$575,862
|
$172,758
|
Lowy, Douglas
|
CCR (NCI)
|
|
Tumor Banking for the Southwest Oncology Group
|
3U24CA114748-05S1
|
$1,125,491
|
$112,549
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Treatment of Melanoma with Optimzed Peptide Vaccines
|
5R01CA136828-02
|
$346,525
|
$346,525
|
Celis, Esteban
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Translational Research in Cancer
|
3P30CA056036-11S1
|
$99,766
|
$3,991
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-11
|
$3,102,433
|
$124,097
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational linkage strategies for DNA vaccines against cancer
|
5F31CA130744-04
|
$41,380
|
$41,380
|
Alonzo, Eric
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Transduction of T cells to improve migration to tumor
|
2R01CA116206-06
|
$353,855
|
$353,855
|
HWU, PATRICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Training Program in Cancer Biology
|
5T32CA078207-12
|
$634,594
|
$209,416
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
TOPIC 285: TARGETED PHOTOTHERMAL ABLATION OF MELANOMA
|
N43CO100052-000
|
$200,000
|
$200,000
|
Goodrich, Glenn
|
Nanospectra BioSciences, Inc.
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035415-27
|
$787,658
|
$7,877
|
MOWAT, REX
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
To Understand/Augment OX40-mediated Tumor Immunotherapy
|
5R01CA102577-07
|
$315,735
|
$157,868
|
WEINBERG, ANDREW
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$456,762
|
$68,514
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Therapeutic Potential of IL-15 Plasmid Delivery to Tumors Using Electroporation
|
5R01CA122518-03
|
$321,694
|
$321,694
|
HELLER, RICHARD
|
OLD DOMINION UNIVERSITY
|
|
Therapeutic approaches that target cancer cell metabolism
|
5K23CA120862-03
|
$137,295
|
$96,107
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma
|
2P50CA093459-06A1
|
$2,300,000
|
$2,300,000
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
Total relevant funding to Melanoma for this search: $102,257,743
|